Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | RGD:1623021 | 6480464 | ethylene dichloride results in decreased expression of PLXNB3 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1623021 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of PLXNB3 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1560615 | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXNB3 mRNA | CTD | PMID:32741896 | 17beta-estradiol 3-benzoate | multiple interactions | ISO | RGD:1560615 | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXNB3 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1623021 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLXNB3 mRNA | CTD | PMID:21570461 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:1560615 | 6480464 | Propylthiouracil results in decreased expression of PLXNB3 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | ISO | RGD:1623021 | 6480464 | Acrylamide results in decreased expression of PLXNB3 mRNA | CTD | PMID:29261810 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of PLXNB3 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of PLXNB3 mRNA | CTD | PMID:32234424 | aflatoxin B2 | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of PLXNB3 polyA tail | CTD | PMID:30157460 | arsenite(3-) | decreases expression | ISO | RGD:1623021 | 6480464 | arsenite results in decreased expression of PLXNB3 mRNA | CTD | PMID:18929588 | arsenite(3-) | multiple interactions | ISO | RGD:1623021 | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of PLXNB3 mRNA] | CTD | PMID:18929588 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzoapyrene results in decreased methylation of PLXNB3 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of PLXNB3 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzoapyrene affects the methylation of PLXNB3 5' UTR more ... | CTD | PMID:27901495, PMID:30157460 | bisphenol A | affects expression | ISO | RGD:1560615 | 6480464 | bisphenol A affects the expression of PLXNB3 mRNA | CTD | PMID:25181051 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of PLXNB3 mRNA | CTD | PMID:26485663 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PLXNB3 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of PLXNB3 mRNA | CTD | PMID:27392435 | copper atom | increases expression | ISO | RGD:1560615 | 6480464 | Copper deficiency results in increased expression of PLXNB3 mRNA | CTD | PMID:26033743 | copper atom | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of PLXNB3 mRNA | CTD | PMID:31162603 | copper(0) | increases expression | ISO | RGD:1560615 | 6480464 | Copper deficiency results in increased expression of PLXNB3 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of PLXNB3 mRNA | CTD | PMID:31162603 | mercury atom | decreases expression | ISO | RGD:1623021 | 6480464 | Mercury analog results in decreased expression of PLXNB3 mRNA | CTD | PMID:25056781 | mercury(0) | decreases expression | ISO | RGD:1623021 | 6480464 | Mercury analog results in decreased expression of PLXNB3 mRNA | CTD | PMID:25056781 | methylmercury chloride | decreases expression | ISO | RGD:1623021 | 6480464 | methylmercuric chloride results in decreased expression of PLXNB3 mRNA | CTD | PMID:29261810 | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of PLXNB3 mRNA | CTD | PMID:26079696 | testosterone | multiple interactions | ISO | RGD:1560615 | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXNB3 mRNA | CTD | PMID:32741896 | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of PLXNB3 mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | RGD:1623021 | 6480464 | triptonide results in increased expression of PLXNB3 mRNA | CTD | PMID:33045310 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of PLXNB3 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | RGD:1623021 | 6480464 | Valproic Acid results in decreased expression of PLXNB3 mRNA | CTD | PMID:29261810 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| Save what matters to you |
| {{ loginError }} |
| Sign in with your RGD account |
| Create New Account | Recover Password |
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Phenotype Annotations Click to see Annotation Detail View
Human Phenotype
Disease Annotations
Click to see Annotation Detail View
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
|
|
|
Gene Ontology Annotations
Click to see Annotation Detail View
Biological Process
|
|
|
Cellular Component
|
|
Molecular Function
|
|
|
Phenotype Annotations
Click to see Annotation Detail View
References
References - curated
| 1. | GOA_HUMAN data from the GO Consortium |
| 2. | RGD automated import pipeline for gene-chemical interactions |
| 3. | Tamagnone L, etal., Cell 1999 Oct 1;99(1):71-80. |
Additional References at PubMed
| PMID:8661155 | PMID:10574462 | PMID:12123608 | PMID:12183458 | PMID:12421765 | PMID:15184888 | PMID:15218527 | PMID:15790807 | PMID:16122393 | PMID:17033634 | PMID:19329067 | PMID:19850054 |
| PMID:20696765 | PMID:21706053 | PMID:21873635 | PMID:29676528 |
Genomics
